Koren Gideon, Cohen Rana
Adelson Faculty of Medicine, Clinical Pharmacology Program, Ariel University, Ariel, Israel.
Motherisk Israel Program, Yitzhak Shamir Medical Center, Be'er Ya'akov, Israel.
Rambam Maimonides Med J. 2020 Jan 30;11(1):1-5. doi: 10.5041/RMMJ.10382.
The increasing medicinal use of cannabis during recent years has largely overlooked children and pregnant women due to litigious and ethical concerns. However, over the last few years medicine has observed increasing numbers of children treated with cannabis for autism spectrum disorder (ASD) and fetal alcohol spectrum disorder (FASD), and pregnant women treated for hyperemesis gravidarum (HG). This review provides an account of major findings discovered through this research. Specifically, cannabis may offer therapeutic advantages to behavioral symptoms of autism spectrum disorder and fetal alcohol spectrum disorder, and to the severe nausea and vomiting in hyperemesis gravidarum. The use of medical cannabis in children and pregnant women should be further discussed and researched in this patient population.
近年来，由于诉讼和伦理方面的担忧，大麻在医疗用途上的增加很大程度上忽视了儿童和孕妇。然而，在过去几年中，医学上观察到越来越多的儿童因自闭症谱系障碍（ASD）和胎儿酒精谱系障碍（FASD）而接受大麻治疗，以及孕妇因妊娠剧吐（HG）而接受大麻治疗。本综述介绍了通过这项研究发现的主要结果。具体而言，大麻可能对自闭症谱系障碍和胎儿酒精谱系障碍的行为症状以及妊娠剧吐中的严重恶心和呕吐具有治疗优势。在这一患者群体中，应进一步讨论和研究儿童和孕妇使用医用大麻的情况。
